Endo ERN
Find an expert
Ukraine
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Ukraine
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

940 publication(s) found matching the search criteria

A new DLK1 defect in a family with idiopathic central precocious puberty: elucidation of the male phenotype


Author(s): Palumbo S, Cirillo G, Sanchez G, Aiello F, Fachin A, Baldo F, Pellegrin MC, Cassio A, Salerno M, Maghnie M, Faienza MF, Wasniewska M, Fintini D, Giacomozzi C, Ciccone S, Miraglia del Giudice E, Tornese G, Grandone A
Affiliated Institution / ERN: AOU University of Campania "Luigi Vanvitelli", Naples ; AOU-Bologna ;
Condition / Disease: DLK1 defect; idiopathic central precocious puberty;
Publication: Journal of Endocrinological Investigation v46.6 p1233-1240 Year: 2022 ORPHAcode / other: ORPHA650182
DOI: 10.1007/s40618-022-01997-y Keywords: DLK1,Genetics,Mutations,Precocious puberty, molecular screening
MTG7

Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study


Author(s): Berton AM, Prencipe N, Bertero L, Baldi M, Bima C, Corsico M, Bianchi A, Mantovani G, Ferraù F, Sartorato P, Gagliardi I, Ghigo E, Grottoli S
Affiliated Institution / ERN: Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease: Acromegaly
Publication: Journal of Clinical Medicine v12.1 p25 Year: 2022 ORPHAcode / other: ORPHA963
DOI: 10.3390/jcm12010025 Keywords: CAM5.2 granulation pattern,SSTR2,first-generation somatostatin receptor ligands,growth hormone-secreting adenoma,magnetic resonance imaging,precision medicine
MTG6

The transition from pediatric to adult care in individuals with Prader-Willi syndrome


Author(s): Poitou C, Holland A, Höybye C, de Graaff LCG, Bottius S, Otterlei B, Tauber M
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections Volume 12: Issue 1 Year: 2022 ORPHAcode / other:
DOI: 10.1530/ec-22-0373 Keywords:
MTG5

Starting point for benchmarking outcomes and reporting of pituitary adenoma surgery within the European Reference Network on Rare Endocrine Conditions (Endo-ERN): results from a meta-analysis and survey study


Author(s): Zamanipoor Najafabadi AH, van der Meulen M, Priego Zurita AL, Ahmed SF, van Furth WR, Charmandari E, Hiort O, Pereira A, Dattani M, Vitali D, de Graaf J, Biermasz N
Affiliated Institution / ERN: Leiden University Medical Center ; Assistance Publique-Hôpitaux de Marseille ; IRCCS Ospedale Policlinico San Martino – Genova ; Universitätsklinikum Schleswig-Holstein ; University Hospital Essen ;
Condition / Disease: Pituitary adenoma
Publication: Endocrine Connections Volume 12: Issue 1 Year: 2022 ORPHAcode / other: ORPHA99408
DOI: 10.1530/ec-22-0349 Keywords: Endo-ERN,pituitary,registry,surgery
MTG6

Doctors, teach your adrenal insufficiency patients well: provide them with a European Emergency Card!


Author(s): Beun JG, Burman P, Kämpe O, Husebye ES, Hahner S, Kristensen J, Noordzij A, Dahlqvist P
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections Volume 12: Issue 1 Year: 2022 ORPHAcode / other:
DOI: 10.1530/EC-22-0345 Keywords:
MTG1

Pure-protein load for children with type 1 diabetes: is any additional insulin needed? A randomized controlled study


Author(s): Dżygało K, Indulska K, Szypowska A
Affiliated Institution / ERN: Public Pediatric Teaching Hospital ;
Condition / Disease: Diabetes mellitus type 1
Publication: Acta Diabetologica v60.3 p337-343 Year: 2022 ORPHAcode / other: ORPHA181371
DOI: 10.1007/s00592-022-02012-9 Keywords: High-protein beverage,Insulin pump,Postprandial glycemia,Pure-protein beverage,Square bolus
MTG3

Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases


Author(s): Webb SM, Kristensen J, Nordenström A, Vitali D, Amodru V, Wiehe LK, Bolz-Johnson M
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections Volume 11: Issue 12 Year: 2022 ORPHAcode / other:
DOI: 10.1530/ec-22-0385 Keywords:

The genetic diagnosis of rare endocrine disorders of sex development and maturation: a survey among Endo-ERN centres


Author(s): Persani L, Cools M, Ioakim S, Faisal Ahmed S, Andonova S, Avbelj-Stefanija M, Baronio F, Bouligand J, Bruggenwirth HT, Davies JH, De Baere E, Dzivite-Krisane I, Fernandez-Alvarez P, Gheldof A, Giavoli C, Gravholt CH, Hiort O, Holterhus P, Juul A, Krausz C, Lagerstedt-Robinson K, McGowan R, Neumann U, Novelli A, Peyrassol X, Phylactou LA, Rohayem J, Touraine P, Westra D, Vezzoli V, Rossetti R
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: DSD
Publication: Endocrine Connections v11.12 Year: 2022 ORPHAcode / other: ORPHA98085; ORPHA2982; ORPHA325546
DOI: 10.1530/ec-22-0367 Keywords: congenital hypogonadotropic hypogonadism,disorders of sex development,next-generation sequencing,primary ovarian insufficiency,rare diseases or syndromes
MTG7

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)


Author(s): van Haalen FM, Kaya M, Pelsma ICM, Dekkers OM, Biermasz NR, Cannegieter SC, Huisman MV, van Vlijmen BJM, Feelders RA, Klok FA, Pereira AM, Stochholm K, Fliers E, Castinetti F, Brue T, Bertherat J, Scaroni C, Colao A, Giordano R, Druce MR, Beckers A, Spranger J, Driessens N, Maiter D, Feldt-Rasmussen U, Feelders R, Webb SM, Dattani M, Husebye E, Zilaitiene B, Gaztambide S, Gatto F, Ferone D, Persani L, Chiodini I, Höybye C, Pereira AM, Biermasz NR, Klok FA, Dekkers OM, Meijer OC, Reincke M, Vila G, Perry C, Heck A, Stancampiano MR, van de Ven A, Johannsson G, Ragnarsson O, Tóth M, Volke V, Toumba M, Canu L, Vojtková J, Al-Mrayat M, Fassnacht M, Detomas M, Karavitaki N, van der Klauw MM, Groselj U, Elenkova A, Unuane D
Affiliated Institution / ERN: Hôpital Universitaire de Bruxelles (HUDERF-Erasme) ; Leiden University Medical Center ; Erasmus MC: University Medical Center Rotterdam ;
Condition / Disease: Cushing syndrome due to cortisol-producing adrenocortical adenoma
Publication: Orphanet Journal of Rare Diseases v17.1 Year: 2022 ORPHAcode / other: ORPHA647758
DOI: DOI: 10.1186/s13023-022-02320-x Keywords: Cushing’s syndrome,Endo-ERN survey,Guidelines,Hemostasis,Hypercortisolism,Thromboprophylaxis,Venous thromboembolism
MTG1 MTG6

Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)


Author(s): Fleseriu M, Biller BMK, Bertherat J, Young J, Hatipoglu B, Arnaldi G, O’Connell P, Izquierdo M, Pedroncelli AM, Pivonello R
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Cushing Disease
Publication: Pituitary v25.6 p959-970 Year: 2022 ORPHAcode / other: ORPHA96253
DOI: 10.1007/s11102-022-01280-6 Keywords: Cortisol,Cushing’s disease,Cushing’s syndrome,Hypercortisolism,Osilodrostat,Steroidogenesis inhibitor
MTG6

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)


Author(s): van Haalen FM, Kaya M, Pelsma ICM, Dekkers OM, Biermasz NR, Cannegieter SC, Huisman MV, van Vlijmen BJM, Feelders RA, Klok FA, Pereira AM, Stochholm K, Fliers E, Castinetti F, Brue T, Bertherat J, Scaroni C, Colao A, Giordano R, Druce MR, Beckers A, Spranger J, Driessens N, Maiter D, Feldt-Rasmussen U, Feelders R, Webb SM, Dattani M, Husebye E, Zilaitiene B, Gaztambide S, Gatto F, Ferone D, Persani L, Chiodini I, Höybye C, Pereira AM, Biermasz NR, Klok FA, Dekkers OM, Meijer OC, Reincke M, Vila G, Perry C, Heck A, Stancampiano MR, van de Ven A, Johannsson G, Ragnarsson O, Tóth M, Volke V, Toumba M, Canu L, Vojtková J, Al-Mrayat M, Fassnacht M, Detomas M, Karavitaki N, van der Klauw MM, Groselj U, Elenkova A, Unuane D
Affiliated Institution / ERN: Bergen Hospital Trust ; Sahlgrenska University Hospital ;
Condition / Disease: Cushings syndrome, thromboprophylaxis
Publication: Orphanet Journal of Rare Diseases v17.1 Year: 2022 ORPHAcode / other: ORPHA:96253; ORPHA647758; ORPHA189427; ORPHA314749
DOI: 10.1186/s13023-022-02320-x Keywords: Cushing’s syndrome,Endo-ERN survey,Guidelines,Hemostasis,Hypercortisolism,Thromboprophylaxis,Venous thromboembolism
MTG6

Behavioral Changes in Patients With Prader-Willi Syndrome Can Mask Severe Physical Illness


Author(s): Van Loo L, Vogels A, Rochtus A
Affiliated Institution / ERN: UZ Leuven ;
Condition / Disease: Prader Willi syndrome
Publication: JCEM Case Reports v1.1 Year: 2022 ORPHAcode / other: ORPHA739
DOI: 10.1210/jcemcr/luac034 Keywords: Prader-Willi syndrome,behavioral changes,severe underlying illness
MTG5

The genetic diagnosis of rare endocrine disorders of sex development and maturation: a survey among Endo-ERN centres


Author(s): Persani L, Cools M, Ioakim S, Faisal Ahmed S, Andonova S, Avbelj-Stefanija M, Baronio F, Bouligand J, Bruggenwirth HT, Davies JH, De Baere E, Dzivite-Krisane I, Fernandez-Alvarez P, Gheldof A, Giavoli C, Gravholt CH, Hiort O, Holterhus P, Juul A, Krausz C, Lagerstedt-Robinson K, McGowan R, Neumann U, Novelli A, Peyrassol X, Phylactou LA, Rohayem J, Touraine P, Westra D, Vezzoli V, Rossetti R
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections Volume11: Issue 12 Year: 2022 ORPHAcode / other:
DOI: 10.1530/ec-22-0367 Keywords:
MTG7

Effect of cabergoline on tumor remnant after surgery in nonfunctioning pituitary adenoma


Author(s): Iglesias P, Biagetti B, Araujo-Castro M, Alcázar V, Guerrero-Pérez F, Rivero N, Casteràs A, Gómez CG, Izquierdo BG, Torres VV, Pascual-Corrales E, Pavón I, Villabona C, Cordido F, Díez JJ
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Non-functioning pituitary adenoma
Publication: Journal of Neuro-Oncology v160.2 p351-359 Year: 2022 ORPHAcode / other: ORPHA91349
DOI: 10.1007/s11060-022-04149-7 Keywords: Cabergoline,Dopamine agonists,Efficacy,Nonfunctioning pituitary adenoma,Safety,Therapeutic outcome
MTG6

Comprehensive genetic testing approaches as the basis for personalized management of growth disturbances: current status and perspectives


Author(s): van der Kaay DCM, Rochtus A, Binder G, Kurth I, Prawitt D, Netchine I, Johannsson G, Hokken-Koelega ACS, Elbracht M, Eggermann T
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections doi.org/10.1530/EC-22-0277 Year: 2022 ORPHAcode / other:
DOI: Keywords:
MTG5

Ictal central sleep‐related apnoea in Prader‐Willi syndrome


Author(s): Giacobbe A, Andreoli L, Mauri E, Pajno R, Patria F, Pinzani R, Costantino AM, Barbieri S, Dilena R
Affiliated Institution / ERN: San Raffaele hospital - Milan ; Foundation IRCCS CA'Granda Ospedale Maggiore polyclinic - Milan ;
Condition / Disease: Prader-Willi syndrome
Publication: Epileptic Disorders v24.5 p957-960 Year: 2022 ORPHAcode / other: ORPHA739
DOI: 10.1684/epd.2022.1455 Keywords:
MTG5

Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios


Author(s): Zafón C, Castelo B
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Non-metastatic Thyroid Carcinoma
Publication: Cancer Medicine v11.S1 p3-4 Year: 2022 ORPHAcode / other: ORPHA100088
DOI: 10.1002/cam4.5154 Keywords:
MTG8

Impact of gender-affirming treatment on bone health in transgender and gender diverse youth


Author(s): Ciancia S, Dubois V, Cools M
Affiliated Institution / ERN:
Condition / Disease:
Publication: Endocrine Connections doi.org/10.1530/EC-22-0280 Year: 2022 ORPHAcode / other:
DOI: Keywords:
MTG7

Stochastic epigenetic mutations as possible explanation for phenotypical discordance among twins with congenital hypothyroidism


Author(s): Gentilini D, Muzza M, de Filippis T, Vigone MC, Weber G, Calzari L, Cassio A, Di Frenna M, Bartolucci M, Grassi ES, Carbone E, Olivieri A, Persani L
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Permanent congenital hypothyroidism
Publication: Journal of Endocrinological Investigation v46.2 p393-404 Year: 2022 ORPHAcode / other: ORPHA226292
DOI: 10.1007/s40618-022-01915-2 Keywords: Congenital diseases,Genome-wide DNA methylation,Preterm delivery,Thyroid,Thyroid dysgenesis,Twin gestation
MTG8

Prader–Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach


Author(s): Barrea L, Vetrani C, Fintini D, de Alteriis G, Panfili FM, Bocchini S, Verde L, Colao A, Savastano S, Muscogiuri G
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Prader Willi Syndrome and Prader Willi-like Syndrome
Publication: Current Obesity Reports v11.4 p263-276 Year: 2022 ORPHAcode / other: ORPHA739
DOI: 10.1007/s13679-022-00478-w Keywords: Diet,Drugs,Ketogenic diet,Nutrition,Nutritionist,Obesity,Prader–Willi syndrome
MTG5

A Critical Evaluation of the EU-virtual consultation platform (CPMS) within the European Reference Network on Rare Endocrine Conditions


Author(s): White EK, Wagner IV, Beuzekom C van, Iotova V, Ahmed SF, Hiort O, Pereira A
Affiliated Institution / ERN: Leiden University Medical Center ; Amsterdam UMC ; Universitätsklinikum Schleswig-Holstein ; UMHAT “Sveta Marina” (Varna) ;
Condition / Disease:
Publication: Endocrine Connections Volume 11: Issue 11 Year: 2022 ORPHAcode / other:
DOI: doi.org/10.1530/EC-22-0281 Keywords:

Pediatric Graves’ orbitopathy: a multicentre study


Author(s): Ionescu IC, van Trotsenburg PAS, Paridaens D, Tanck M, Mooij CF, Cagienard E, Kalmann R, Pakdel F, van der Meeren S, Saeed P
Affiliated Institution / ERN: Amsterdam UMC ; Erasmus MC: University Medical Center Rotterdam ; University Medical Center Utrecht ; Leiden University Medical Center ;
Condition / Disease: Paediatric-onset Graves disease
Publication: Acta Ophthalmologica v100.6 Year: 2022 ORPHAcode / other: ORPHA525731
DOI: 10.1111/aos.15084 Keywords: Graves’ disease,Graves’ orbitopathy,orbital decompression,paediatric,rehabilitative surgery,severity,thyroid eye disease
MTG8

Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE)


Author(s): Isidori AM, Aversa A, Calogero A, Ferlin A, Francavilla S, Lanfranco F, Pivonello R, Rochira V, Corona G, Maggi M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease:
Publication: Journal of Endocrinological Investigation v45.12 p2385-2403 Year: 2022 ORPHAcode / other:
DOI: 10.1007/s40618-022-01859-7 Keywords: Bone mineral density,Erectile dysfunction,Hypogonadism,Late-onset hypogonadism,Metabolic syndrome,Obesity,Testosterone

Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study


Author(s): Feola T, Pirchio R, Puliani G, Pofi R, Crocco M, Sada V, Sesti F, Verdecchia F, Gianfrilli D, Appetecchia M, Di Iorgi N, Jaffrain-Rea ML, Pivonello R, Isidori AM, Grossman AB, Sbardella E, Savage AM, Foresta C, Krausz C, Durante C, De Martino MC, Paoli D, Ferrigno R, Caiulo S, Minnetti M, Hasenmajer V, Pozza C, Kanakis G, Cangiano B, Tenuta M, Petrozzi A, Carlomagno F, Di Nisio A, Pallotti F, Tarsitano MG, Spaziani M, Cargnelutti F, Sabovic I, Grani G, Virili C, Cozzolino A, Stramazzo I, Filardi T, Mazzotta P
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Craniopharyngioma
Publication: Journal of Endocrinological Investigation v46.1 p181-188 Year: 2022 ORPHAcode / other:
DOI: 10.1007/s40618-022-01900-9 Keywords: Adolescence,Parasellar lesions,Pituitary tumours,Sellar,Transition age,Young adults
MTG6

Time With Glucose Level in Target Range Among Children and Adolescents With Type 1 Diabetes After a Software Update to a Closed-Loop Glucose Control System


Author(s): Marigliano M, Scaramuzza AE, Bonfanti R, Rabbone I, Schiaffini R, Toni S, Cherubini V, Abate Daga F, Bassi M, Berioli MG, Bruzzi P, Calandretti M, Carducci C, Cavalli C, Delvecchio M, Gesuita R, Giorda S, Iafusco D, Lenzi L, Lombardo F, Lo Presti D, Maffeis C, Maltoni G, Mameli C, Marino M, Piccini B, Minuto N, Mozzillo E, Piccinno E, Pignatiello C, Predieri B, Redaelli FC, Ricciardi MR, Rigamonti A, Ripoli C, Rosanio FM, Salzano G, Savastio S, Tiberi V, Tinti D, Trada M, Zanetta S, Zanfardino A, Zucchini S
Affiliated Institution / ERN: Meyer Children’s Hospital Florence ; AOU-Bologna ;
Condition / Disease:
Publication: JAMA Network Open v5.8 pe2228669 Year: 2022 ORPHAcode / other:
DOI: 10.1001/jamanetworkopen.2022.28669 Keywords:
MTG3

Multidisciplinary integrated care pathway for von Hippel–Lindau disease


Author(s): Wolters WPG, Dreijerink KMA, Giles RH, van der Horst‐Schrivers ANA, van Nesselrooij B, Zandee WT, Timmers HJLM, Seute T, de Herder WW, Verrijn Stuart AA, Kilic E, Brinkman WM, Zondervan PJ, Vandertop WP, Daniels AB, Wolbers T, Links TP, van Leeuwaarde RS
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: VHL Syndrome
Publication: Cancer v128.15 p2871-2879 Year: 2022 ORPHAcode / other: ORPHA892
DOI: 10.1002/cncr.34265 Keywords: care pathway,hemangioblastoma,pancreatic neuroendocrine tumor,renal cell carcinoma,retinal angioma,von Hippel-Lindau (VHL)
MTG4

Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers


Author(s): Montero‐Conde C, Leandro‐García LJ, Martínez‐Montes ÃM, Martínez P, Moya FJ, Letón R, Gil E, Martínez‐Puente N, Guadalix S, Currás‐Freixes M, García‐Tobar L, Zafon C, Jordà M, Riesco‐Eizaguirre G, González‐García P, Monteagudo M, Torres‐Pérez R, Mancikova V, Ruiz‐Llorente S, Pérez‐Martínez M, Pita G, Galofré JC, Gonzalez‐Neira A, Cascón A, Rodríguez‐Antona C, Megías D, Blasco MA, Caleiras E, Rodríguez‐Perales S, Robledo M
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Non-metastatic Thyroid Carcinoma
Publication: Clinical and Translational Medicine v12.8 Year: 2022 ORPHAcode / other: ORPHA100088
DOI: 10.1002/ctm2.1001 Keywords: 5p-end FISH,TERC,TERT promoter methylation,TERT promoter mutation,subtelomeric gene expression,telomere shortening
MTG8

The importance of kidney calcium handling in the homeostasis of extracellular fluid calcium


Author(s): Prot-Bertoye C, Lievre L, Houillier P
Affiliated Institution / ERN: Reference centre for rare diseases of calcium and phosphate-HEGP ;
Condition / Disease:
Publication: Pflügers Archiv - European Journal of Physiology v474.8 p885-900 Year: 2022 ORPHAcode / other:
DOI: 10.1007/s00424-022-02725-4 Keywords: Calcium-sensing receptor,Claudin,Paracellular ion transport,Parathyroid hormone,TRPV5,Tight junction,Transcellular ion transport

A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes


Author(s): Scaramuzza AE, Cherubini V, Schiaffini R, Rabbone I, Gallo F, Fichera G, Arnaldi C, Bonfanti R, Lombardo F, De Marco R, Pascarella F, Tornese G, Bobbio A, Suprani T, Minuto N, Franceschi R, Piccinno E, Mozzillo E, Savastio S, Piccini B, Frongia AP, Mameli C, Musolino G, Toni S, Randazzo E, Frontino G, Delvecchio M, Sogno Valin P, Reinstadler P, Calcaterra V, De Sanctis L, Trada M, Coccioli MS, Guerraggio LP, Citriniti F, Lasagni A, Rutigliano I, Stamati FA, De Berardinis F, Zampolli M, Maltoni G, Fornari E, Ripoli C, Gaiero A, Sordelli S, d’Annunzio G, Predieri B, Cardinale G, Cardella F, Iafusco D, Corò A, Zucchini S, Maffeis C, Giani E, Tinti D, Cavalli C
Affiliated Institution / ERN: Meyer Children’s Hospital Florence ; AOU-Bologna ;
Condition / Disease:
Publication: Acta Diabetologica v59.8 p1109-1111 Year: 2022 ORPHAcode / other:
DOI: 10.1007/s00592-022-01885-0 Keywords: Adolescents,COVID-19,Children,Type 1 diabetes,Vaccination,Vaccine

Are there country-specific differences in the use of pegvisomant for acromegaly in clinical practice? An analysis from ACROSTUDY


Author(s): Grottoli S, Bianchi A, Bogazzi F, Bona C, Carlsson MO, Colao A, Dassie F, Giampietro A, Gomez R, Granato S, Maffei P, Pivonello R, Prencipe N, Ragonese M, Urbani C, Cannavò S
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: Acromegaly
Publication: Journal of Endocrinological Investigation v45.8 p1535-1545 Year: 2022 ORPHAcode / other: ORPHA963
DOI: 10.1007/s40618-022-01789-4 Keywords: Acromegaly,Effectiveness,Pegvisomant,Real-world analysis,Safety,Treatment schemes
MTG6
Page 15 of 32« First«...10...1314151617...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2026. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance